{"title":"DMC在北卡罗来纳州开设研发设施","authors":"None Craig Bettenhausen","doi":"10.1021/cen-10137-buscon8","DOIUrl":null,"url":null,"abstract":"The biobased chemicals firm DMC Biotechnologies has opened an 880 m 2 R&D site in Research Triangle, North Carolina. DMC uses custom microbes to ferment a range of nutritional ingredients and other specialty chemicals. The facility will house strain and process development labs, analytical suites, and pilot-scale fermentation lines. DMC already has a lab in Boulder, Colorado, focused on isolating products after fermentation.","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"28 23","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DMC opens R&D facility in North Carolina\",\"authors\":\"None Craig Bettenhausen\",\"doi\":\"10.1021/cen-10137-buscon8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The biobased chemicals firm DMC Biotechnologies has opened an 880 m 2 R&D site in Research Triangle, North Carolina. DMC uses custom microbes to ferment a range of nutritional ingredients and other specialty chemicals. The facility will house strain and process development labs, analytical suites, and pilot-scale fermentation lines. DMC already has a lab in Boulder, Colorado, focused on isolating products after fermentation.\",\"PeriodicalId\":9517,\"journal\":{\"name\":\"C&EN Global Enterprise\",\"volume\":\"28 23\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C&EN Global Enterprise\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1021/cen-10137-buscon8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C&EN Global Enterprise","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/cen-10137-buscon8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The biobased chemicals firm DMC Biotechnologies has opened an 880 m 2 R&D site in Research Triangle, North Carolina. DMC uses custom microbes to ferment a range of nutritional ingredients and other specialty chemicals. The facility will house strain and process development labs, analytical suites, and pilot-scale fermentation lines. DMC already has a lab in Boulder, Colorado, focused on isolating products after fermentation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
